Impact of Neuropsychological Disorders in Multiple Sclerosis
NCT ID: NCT04837365
Last Updated: 2025-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2021-05-21
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The patient will benefit from:
* A routine neuropsychological assessment, including a cognitive and emotional assessment
* A clinical examination
* A three-dimensional analysis of movement
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electrophysiological Study of Spatiotemporal Gait Parameters in Patients in Early Stage of Multiple Sclerosis
NCT02896933
Psychometric Properties Upper Limb Function Measures Multiple Sclerosis
NCT02339675
Auditory-motor Coupling in Multiple Sclerosis With Cerebellar Lesions
NCT04639401
Walking and Thinking - Brain Activity During Complex Walking in People With Multiple Sclerosis
NCT05787704
Nature of the Link Between Executive Functions and Theory of Mind in Multiple Sclerosis
NCT04806217
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with neuropsychological disorders
Three dimensional gait analysis with eyetracking
An emotional impregnation and eye pursuit assessment are specific to the study. Emotional impregnation involves making the patient look at images from the International Affective Picture System (IAPS) on a screen before initiating walking. The equipment will be identical to that of the patient during walking tasks. Eye movement analysis is performed using a pair of eyetracking glasses.
patients without neuropsychological disorders
Three dimensional gait analysis with eyetracking
An emotional impregnation and eye pursuit assessment are specific to the study. Emotional impregnation involves making the patient look at images from the International Affective Picture System (IAPS) on a screen before initiating walking. The equipment will be identical to that of the patient during walking tasks. Eye movement analysis is performed using a pair of eyetracking glasses.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Three dimensional gait analysis with eyetracking
An emotional impregnation and eye pursuit assessment are specific to the study. Emotional impregnation involves making the patient look at images from the International Affective Picture System (IAPS) on a screen before initiating walking. The equipment will be identical to that of the patient during walking tasks. Eye movement analysis is performed using a pair of eyetracking glasses.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Carriers of MS with relapsing remitting form (RRMS-RR) with an EDSS \<4
* No significant motor, cerebellar or somesthesia disorders of the upper limbs or visual disturbances (side to a visual EDSS \<2)
* Absence of corticosteroid intake in the last four weeks
* Benefiting from health insurance coverage
* Not showing any flare-ups or worsening of the disease in the last 6 weeks
* No botulinum toxin injection for more than 4 months
Exclusion Criteria
* Treatment with psychotropic drugs (except benzodiazepines and hypnotics).
* Refusal to participate after clear and fair information about the study.
* Adults under tutorship, curatorship or safeguard of justice
* With orthopedic treatment influencing walking
* Pregnant woman
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lille Catholic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Caroline Massot, MD
Role: STUDY_DIRECTOR
GHICL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Vincent hospital - neurological service
Lille, , France
St Philibert hospital - Neurologial service
Lomme, , France
St Philibert hospital - Physical Medicine and Rehabilitation
Lomme, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Brunno Lenne, PhD
Role: primary
Arnaud Kwiatkowski, MD
Role: primary
Caroline Massot, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC-P00108
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.